3.490CHF0.00%Mkt Cap: 149.41M $P/E: —Today
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP03…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap149.41M $
Enterprise Value63.33M $
Revenue (TTM)—
Gross Profit-41.84M $
Net Income (TTM)-70.36M $
Revenue/Share—
Last Price3.490 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees134
CountryCH
SectorHealthcare
IndustryBiotechnology
ISINCH0256379097
Valuation
P/E (Trailing)—
P/E (Forward)14.98
PEG—
EV/EBITDA-1.07
EV/Revenue—
P/S—
P/B1.90
EPS (TTM)-1.55
EPS (Forward)0.23
52W Range
2.66064% of range3.960
52W High3.960 CHF
52W Low2.660 CHF
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-76.74%
ROA-60.38%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-58.50M $
CapEx (TTM)814.89K $
FCF Margin—
FCF Yield-19.25%
Net Debt-86.08M $
Net Debt/EBITDA1.45
Balance Sheet
Debt/Equity0.05
Current Ratio9.43
Quick Ratio9.21
Book Value/Sh1.825 CHF
Cash/Share2.100 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.000 CHF
Upside (mean)+157.9%
Target Range3.000 CHF – 15.00 CHF
CHF3.000+157.9% to meanCHF15.00
# Analysts2
Ownership
Shares Out.37.51M
Float19.92M
Insiders8.47%
Institutions43.74%
Technical
SMA 503.212 (+8.6%)
SMA 2003.313 (+5.3%)
Beta0.68
S&P 52W Chg18.16%
Avg Vol (30d)11.68K
Avg Vol (10d)11.71K
Technical Indicators
RSI (14)65.5
MACD0.0625
MACD Signal0.0441
MACD Hist.+0.0184
BB Upper3.493 CHF
BB Middle3.307 CHF
BB Lower3.121 CHF
BB Width11.26%
ATR (14)0.0985 CHF
Vol Ratio (20d)2.22x